Clinical Trials

Nutra Pharma Corporation , a biotechnology company marketing Nyloxin® and Pet Pain-Away™ in the over-the-counter (OTC) pain management market, and...

Recro Pharma, Inc. , a revenue generating specialty pharmaceutical company focused on therapeutics for hospital and other acute care settings...

Lexicon Pharmaceuticals announced additional positive data from the Phase 3 inTandem1 study.                ...

Milestone Pharmaceuticals Montreal, Canada, Inc., a clinical stage cardiovascular compan announced positive data from its Phase 2 NODE-1 trial evaluating...

POXEL SA , a biopharmaceutical company focused on the development of innovative drugs to treat metabolic diseases, including type 2...

Chugai Pharmaceutical Co., Ltd. announced that Alecensa as an initial (first-line) treatment showed that patients lived significantly longer without disease...

Kyowa Hakko Kirin Co., Ltd. announced the Global Phase 3 study (MAVORIC: Mogamulizumab anti-CCR4 Antibody Versus ComparatOR In CTCL) investigating the...

Takeda Pharmaceutical Company Limited announced that it has completed enrollment of 20,100 children and adolescents ages 4 through 16in its...

Glenmark Pharmaceuticals, a global pharmaceutical company announced positive results for GSP 301, an investigational fixed-dose combination of mometasone furoate (25...

Icertis, the leading provider of enterprise contract management in the cloud announced an upgrade to the Icertis Clinical Trial Agreement...